Recordati SpA (MEX:RECN) Total Receivables: MXN15,942 Mil (As of Mar. 2026)


MEX:RECN Recordati SpA MEX:RECN
71 GF Score
Price MXN1,019.79
GF Value MXN1,150.23
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Recordati SpA Total Receivables?

Recordati SpA MEX:RECN 71 Total Receivables is MXN15,942 Mil as of Mar. 2026. GuruFocus rates MEX:RECN with a GF Score™ of 71/100 and a GF Value™ of MXN1,150.23 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Recordati SpA's Total Receivables for the quarter that ended in Mar. 2026 was MXN15,942 Mil.

Recordati SpA Total Receivables Related Terms

Recordati SpA Total Receivables Historical Data

* Premium members only.

The historical data trend for Recordati SpA's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Recordati SpA Total Receivables Chart

Recordati SpA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7,310.68 7,738.67 8,686.85 11,866.59 12,440.61

Recordati SpA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15,621.99 15,207.37 15,066.34 12,440.61 15,942.32
MEX:RECN
71GF Score
Recordati SpA MEX:RECN
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Recordati SpA Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of MXN15,942 Mil mean?
Recordati SpA (MEX:RECN) has a Total Receivables of MXN15,942 Mil as of Mar. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Recordati SpA and its competitors.
Is Recordati SpA's Total Receivables too high?
Recordati SpA's current Total Receivables is MXN15,942 Mil. Overall, Recordati SpA has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Recordati SpA's Total Receivables compare to LLY and JNJ?
Recordati SpA's Total Receivables of MXN15,942 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Drug Manufacturers company?
A good Total Receivables depends on the Drug Manufacturers industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Recordati SpA and its competitors. Recordati SpA's current Total Receivables is MXN15,942 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Recordati SpA stock overvalued right now?
Based on GuruFocus' analysis, Recordati SpA (MEX:RECN) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN1,150.23, compared to a current price of MXN1,019.79 — trading 11.3% below its estimated fair value. The current Total Receivables is MXN15,942 Mil. Recordati SpA's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Recordati SpA (MEX:RECN), the current Total Receivables is MXN15,942 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Recordati SpA (MEX:RECN) Overvalued in 2026?

Based on GuruFocus' analysis, Recordati SpA stock appears to be undervalued. The current stock price of MXN1,019.79 is trading 11.3% below its estimated GF Value™ of MXN1,150.23. GuruFocus considers Recordati SpA to be Modestly Undervalued.

Key valuation signals for MEX:RECN:

  • Total Receivables: MXN15,942 Mil
  • GF Value™: MXN1,150.23 vs. price of MXN1,019.79 (11.3% below fair value)
  • GF Score™: 71/100 with 3 warning signs

No single metric tells the full story. See the MEX:RECN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Recordati SpA Business Description

Address Via Matteo Civitali 1, MIlan, ITA, 20148
Recordati SpA is engaged in the development, production, and marketing of pharmaceutical products or of pharmaceutical chemicals. The Company operates in a broad and diverse context, which includes general medicine, specialist medicine, self-medication, and rare diseases. In addition, it is also active in the field of urology, with treatments for benign prostatic hyperplasia and male functional disorders, and in psychiatry. The Company's only operating segment is the Specialty & Primary Care segment. Its geographic areas are Europe, Australasia, America, and Africa.
71GF Score

Get the complete analysis for MEX:RECN

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,019.79
Price
MXN1,150.23
GF Value